Renvela and Intelence drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Renvela (sevelamer carbonate) and Intelence (etravirine). Common drug interactions include chronic kidney disease among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Renvela and Intelence. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.

What is Intelence?

Intelence has active ingredients of etravirine. It is often used in hiv infection. eHealthMe is studying from 3,797 Intelence users. Check the latest studies of Intelence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

29 people who take Renvela and Intelence together, and have interactions are studied.

Renvela and Intelence drug interactions.

What are the common drug interactions of Renvela and Intelence, by gender? *:

female:

Chronic kidney disease
Emotional distress
Pain
Anxiety
Bone density decreased
Depression
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Nephrogenic anaemia (anaemia due to kidney disease)
Osteoporosis (bones weak and more likely to break)

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Quality of life decreased
Renal tubular necrosis (death of kidney tubules)
Depression
Gout (uric acid crystals building up in the body)
Impaired work ability
Mobility decreased (ability to move is reduced)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pancreatitis acute (sudden inflammation of pancreas)

What are the common drug interactions of Renvela and Intelence, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain

30-39:

Anxiety
Emotional distress
Pain
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Chronic kidney disease
Fatigue (feeling of tiredness)
Quality of life decreased
Impaired work ability
Mobility decreased (ability to move is reduced)

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Chronic kidney disease
Bone density decreased
Osteopenia (a condition where bone mineral density is lower than normal)
Protein total increased
Renal impairment (severely reduced kidney function)
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)

50-59:

Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Renal failure (kidney dysfunction)
Osteoporosis (bones weak and more likely to break)
Renal tubular necrosis (death of kidney tubules)
Bone density decreased
Depression

60+:

Bone density decreased
Chronic kidney disease
Renal failure (kidney dysfunction)
Tooth fracture
Tooth loss
Abdominal pain
Asthenia (weakness)
Dizziness
Emotional distress
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

What are the existing conditions these people have? *

Hiv Infection: 27 people, 93.10%
High Blood Pressure: 9 people, 31.03%
High Blood Cholesterol: 6 people, 20.69%
Pain: 5 people, 17.24%
Stress And Anxiety: 5 people, 17.24%
Nasopharyngitis (inflammation of the nasopharynx): 5 people, 17.24%
Depression: 4 people, 13.79%
Asthma: 4 people, 13.79%
Muscle Spasms (muscle contraction): 4 people, 13.79%
Oropharyngeal Pain: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Renvela and Intelence?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously